Search Results

Filter
  • 1-10 of  144 results for ""Cholesterol Ester Transfer Proteins""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia.

  • Authors : Aguchem RN; Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Enugu State 410001, Nigeria.; Okagu IU

Subjects: Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/metabolism ; Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/antagonists & inhibitors ; Proprotein Convertase 9*/Proprotein Convertase 9*/Proprotein Convertase 9*/metabolism

  • Source: Life sciences [Life Sci] 2024 Aug 15; Vol. 351, pp. 122823. Date of Electronic Publication: 2024 Jun 10.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.

  • Authors : Ference BA; Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, Michigan.; Institute for Advanced Studies, University of Bristol, Bristol, United Kingdom.

Subjects: Genetic Variation*; Apolipoproteins B/Apolipoproteins B/Apolipoproteins B/*blood ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*genetics

  • Source: JAMA [JAMA] 2017 Sep 12; Vol. 318 (10), pp. 947-956.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.

  • Authors : Thomas T; From the Columbia University, New York (T.T., W.K., R.R., S.H., H.N.G., G.R.-S.); Merck & Co, Inc, Kenilworth, NJ (H.Z., Y.L., P.J., J.A.W., B.H., S.F.P., T.R., A.O.J.-L., D.E.G.)

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Hypercholesterolemia/Hypercholesterolemia/Hypercholesterolemia/*drug therapy

  • Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2017 Sep; Vol. 37 (9), pp. 1770-1775. Date of Electronic Publication: 2017 Jul 20.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice.

  • Authors : Li J; From the Graduate Center for Nutritional Sciences (J.L., R.E.T., D.R.v.d.W., G.A.G.), University of Kentucky, Lexington.; Department of Pharmacology and Nutritional Sciences (J.L.), University of Kentucky, Lexington.

Subjects: Bile Acids and Salts/Bile Acids and Salts/Bile Acids and Salts/*metabolism ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*metabolism ; Gastrointestinal Motility/Gastrointestinal Motility/Gastrointestinal Motility/*physiology

  • Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2019 Oct; Vol. 39 (10), pp. 1986-1995. Date of Electronic Publication: 2019 Aug 29.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels.

  • Authors : Lee CJ; Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.; Park MS

Subjects: Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*genetics ; Cholesterol, HDL/Cholesterol, HDL/Cholesterol, HDL/*blood ; Hypercholesterolemia/Hypercholesterolemia/Hypercholesterolemia/*genetics

  • Source: Scientific reports [Sci Rep] 2019 Jul 29; Vol. 9 (1), pp. 10915. Date of Electronic Publication: 2019 Jul 29.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The controversy over the use of cholesteryl ester transfer protein inhibitors: is there some light at the end of the tunnel?

  • Authors : Quintão EC; Internal Medicine, University of Sao Paulo Medical School, Sao Paulo, Brazil.

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*metabolism

  • Source: European journal of clinical investigation [Eur J Clin Invest] 2016 Jun; Vol. 46 (6), pp. 581-9. Date of Electronic Publication: 2016 Apr 15.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

×
Academic Journal

The effect of APOE, CETP, and PCSK9 polymorphisms on simvastatin response in Thai hypercholesterolemic patients.

Subjects: Apolipoproteins E/Apolipoproteins E/Apolipoproteins E/*genetics ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*genetics ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use

  • Source: Cardiovascular therapeutics [Cardiovasc Ther] 2017 Dec; Vol. 35 (6). Date of Electronic Publication: 2017 Sep 25.Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-5922

Record details

×
Academic Journal

APOE and CETP TaqIB polymorphisms influence metabolic responses to Hibiscus sabdariffa L. and Gynostemma pentaphyllum Makino tea consumption in hypercholesterolemic subjects.

  • Authors : Jeenduang N; School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand. Email: .; Sangkaew B

Subjects: Apolipoproteins E/Apolipoproteins E/Apolipoproteins E/*genetics ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*genetics ; Gynostemma/Gynostemma/Gynostemma/*chemistry

  • Source: Asia Pacific journal of clinical nutrition [Asia Pac J Clin Nutr] 2017 Mar; Vol. 26 (2), pp. 368-378.Publisher: Qingdao University Country of Publication: China NLM ID: 9440304 Publication Model: Print Cited Medium: Print ISSN: 0964-7058 (Print)

Record details

×
Academic Journal

Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms.

  • Authors : Sofat R; Centre for Clinical Pharmacology, Department of Medicine, University College London, London, United Kingdom.; Hingorani AD

Subjects: Hypercholesterolemia*/Hypercholesterolemia*/Hypercholesterolemia*/drug therapy ; Hypercholesterolemia*/Hypercholesterolemia*/Hypercholesterolemia*/epidemiology ; Hypercholesterolemia*/Hypercholesterolemia*/Hypercholesterolemia*/genetics

  • Source: Circulation [Circulation] 2010 Jan 05; Vol. 121 (1), pp. 52-62. Date of Electronic Publication: 2009 Dec 21.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?

  • Authors : Barter P; The Heart Research Institute, 7 Eliza Street, Newtown, Sydney 2042, Australia. ; Rye KA

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: Trends in pharmacological sciences [Trends Pharmacol Sci] 2011 Dec; Vol. 32 (12), pp. 694-9. Date of Electronic Publication: 2011 Nov 14.Publisher: Published By Elsevier In Association With The International Union Of Pharmacology Country of Publication: England NLM ID: 7906158 Publication Model:

Record details

×
  • 1-10 of  144 results for ""Cholesterol Ester Transfer Proteins""